Literature DB >> 14731182

Histologic findings at augmented bone areas supplied with two different bone substitute materials combined with sinus floor lifting. Report of one case.

Rolf Ewers1, Walter Goriwoda, Christian Schopper, Doris Moser, Else Spassova.   

Abstract

This case report is focused on the histologic findings of bone tissue supplied with two different hydroxyapatites (HAs) used for maxillary sinus floor grafting in the same patient after various healing intervals. An insufficient unilateral sinus floor grafting with Bio-Oss biomaterial was followed by an additional grafting procedure with Algipore biomaterial performed 4 years later. Bone samples obtained during second-stage dental implantation contained the interesting combination of Bio-Oss, a bovine anorganic bone substitute, and Algipore, a porous algae-derived HA, in close vicinity, yet after different healing periods. Light microscopy exhibited satisfactory osseointegration of both grafting materials. However, Bio-Oss biomaterial showed no evidence of substantial remodeling after a healing period of 4.5 years. On the other hand, Algipore particles demonstrated signs of remodeling by being locally resorbed and partially replaced with newly formed bone already within 6 months.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14731182     DOI: 10.1111/j.1600-0501.2004.00987.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  8 in total

1.  Sinus augmentation with phycogene hydroxyapatite: histological and histomorphometrical results after 6 months in humans. A case series.

Authors:  Antonio Scarano; Marco Degidi; Vittoria Perrotti; Adriano Piattelli; Giovanna Iezzi
Journal:  Oral Maxillofac Surg       Date:  2011-09-24

2.  Compositional and histological comparison of carbonate apatite fabricated by dissolution-precipitation reaction and Bio-Oss®.

Authors:  Kenji Fujisawa; Kazuya Akita; Naoyuki Fukuda; Kumiko Kamada; Takaharu Kudoh; Go Ohe; Takamitsu Mano; Kanji Tsuru; Kunio Ishikawa; Youji Miyamoto
Journal:  J Mater Sci Mater Med       Date:  2018-07-21       Impact factor: 3.896

3.  Effect of low-level laser on bone defects treated with bovine or autogenous bone grafts: in vivo study in rat calvaria.

Authors:  Mércia J S Cunha; Luis A Esper; Michyele C Sbrana; Paula G F P de Oliveira; Accácio L do Valle; Ana Lúcia P F de Almeida
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

4.  Comparative Evaluation of Bioactive Synthetic NovaBone Putty and Calcified Algae-derived Porous Hydroxyapatite Bone Grafts for the Treatment of Intrabony Defects.

Authors:  Nitika N Bembi; Sumit Bembi; Jyoti Mago; Gurpreet Kaur Baweja; Parvinder Singh Baweja
Journal:  Int J Clin Pediatr Dent       Date:  2016-12-05

5.  Histologic and Histomorphometric Analysis of Bone Regeneration with Bovine Grafting Material after 24 Months of Healing. A Case Report.

Authors:  Renzo Guarnieri; Fabrizio Belleggia; Patricia DeVillier; Luca Testarelli
Journal:  J Funct Biomater       Date:  2018-08-08

6.  Efficient in vivo bone formation by BMP-2 engineered human mesenchymal stem cells encapsulated in a projection stereolithographically fabricated hydrogel scaffold.

Authors:  Hang Lin; Ying Tang; Thomas P Lozito; Nicholas Oyster; Bing Wang; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2019-08-14       Impact factor: 6.832

7.  Histological and micro-computed tomographic observations after maxillary sinus augmentation with porous hydroxyapatite alloplasts: a clinical case series.

Authors:  Hidemi Nakata; Shinji Kuroda; Noriko Tachikawa; Emi Okada; Maho Akatsuka; Shohei Kasugai; Hisatomo Kondo
Journal:  Springerplus       Date:  2016-03-02

8.  Injectable BMP-2 gene-activated scaffold for the repair of cranial bone defect in mice.

Authors:  Kai Sun; Hang Lin; Ying Tang; Shiqi Xiang; Jingwen Xue; Weifeng Yin; Jian Tan; Hao Peng; Peter G Alexander; Rocky S Tuan; Bing Wang
Journal:  Stem Cells Transl Med       Date:  2020-08-12       Impact factor: 6.940

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.